- Home
- NAMS vs LBTYB Comparison
NAMS vs LBTYB Comparison
Compare NAMS & LBTYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | LBTYB |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | Netherlands | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NAMS | LBTYB |
|---|---|---|
| Price | $34.87 | $11.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $46.40 | N/A |
| AVG Volume (30 Days) | ★ 978.9K | 1.7K |
| Earning Date | 11-05-2025 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $35,243,000.00 | ★ $4,770,600,000.00 |
| Revenue This Year | N/A | $13.82 |
| Revenue Next Year | N/A | $1.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.91 | ★ 170.50 |
| 52 Week Low | $14.06 | $9.15 |
| 52 Week High | $42.00 | $13.59 |
Technical Indicators
Market Signals| Indicator | NAMS | LBTYB |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 58.37 |
| Support Level | $33.91 | $11.10 |
| Resistance Level | $36.00 | $11.50 |
| Average True Range (ATR) | 1.50 | 0.19 |
| MACD | -0.04 | 0.05 |
| Stochastic Oscillator | 43.64 | 80.56 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About LBTYB Liberty Global Ltd. Class B
Liberty Global is a holding company with interests in European telecom companies in the UK, the Netherlands, Belgium, Ireland, and Slovakia. Liberty owns the main cable network in each of these geographies and has pursued a strategy since 2016 to merge or partner with mobile network operators to be able to offer converged services. Liberty also owns minority stakes in other media, entertainment, and cloud companies.